The European Commission has just published a study on impacts of REACH authorisation. This study looks at EU market changes for substances of very high concern (SVHCs) and their alternatives, examples of substitution, the costs and benefits of authorisation and affordability for small and medium sized enterprises.

Further information can be found in ECHA’s weekly news.